| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | zonula adherens maintenance | 4.01e-05 | 3 | 76 | 2 | GO:0045218 | |
| GeneOntologyBiologicalProcess | cerebellum maturation | 8.00e-05 | 4 | 76 | 2 | GO:0021590 | |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A SOX9 TOX GLI1 SH3GL2 MXRA8 SEC16A KNDC1 MAFB RERE BAG6 NR2F1 NR2F2 TP73 | 1.06e-04 | 1197 | 76 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | CACNA1A SOX9 TOX GLI1 SEC16A KNDC1 MAFB RERE BAG6 NR2F1 NR2F2 TP73 | 1.27e-04 | 919 | 76 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.37e-04 | 71 | 76 | 4 | GO:0021695 | |
| Domain | COUP_TF | 1.45e-04 | 5 | 72 | 2 | IPR003068 | |
| Domain | AGC-kinase_C | 1.32e-03 | 56 | 72 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.32e-03 | 56 | 72 | 3 | PS51285 | |
| Domain | S_TK_X | 1.32e-03 | 56 | 72 | 3 | SM00133 | |
| Domain | - | 1.38e-03 | 57 | 72 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.46e-03 | 58 | 72 | 3 | IPR013088 | |
| Domain | BAR | 1.49e-03 | 15 | 72 | 2 | SM00721 | |
| Domain | BAR | 1.49e-03 | 15 | 72 | 2 | PF03114 | |
| Domain | BAR_dom | 1.70e-03 | 16 | 72 | 2 | IPR004148 | |
| Domain | HMG_box_dom | 2.02e-03 | 65 | 72 | 3 | IPR009071 | |
| Domain | BAR | 2.40e-03 | 19 | 72 | 2 | PS51021 | |
| Domain | SAM | 4.77e-03 | 88 | 72 | 3 | SM00454 | |
| Domain | SAM_DOMAIN | 5.90e-03 | 95 | 72 | 3 | PS50105 | |
| Domain | - | 5.95e-03 | 30 | 72 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 5.95e-03 | 30 | 72 | 2 | IPR027267 | |
| Domain | SAM | 6.25e-03 | 97 | 72 | 3 | IPR001660 | |
| Domain | - | 7.98e-03 | 106 | 72 | 3 | 1.10.150.50 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 ARHGEF40 LATS2 PIK3C2B SETD5 GLI1 SPEG SEC16A ARHGAP17 TANC1 ATG9A PUM1 CDC42BPB NR2F2 C8orf58 PHC2 | 3.19e-09 | 1105 | 79 | 16 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 PIK3C2B KIAA1217 SEC16A ARHGAP17 TANC1 CUL7 UBN2 NCKAP5L CNOT3 SLX4 TP73 | 8.92e-09 | 588 | 79 | 12 | 38580884 |
| Pubmed | 1.58e-07 | 263 | 79 | 8 | 34702444 | ||
| Pubmed | 4.84e-07 | 28 | 79 | 4 | 29365100 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 MAST4 PIK3C2B KIAA1217 CAMSAP3 SEC16A ARHGAP17 TANC1 PUM1 NCKAP5L PLEKHA7 OTOG | 5.50e-07 | 861 | 79 | 12 | 36931259 |
| Pubmed | LENG8 SOX9 BCL9L RNF214 HIVEP1 SATB1 SEC16A RERE CUL7 SPATA2 PUM1 UBN2 PRRC2A CNOT3 SLX4 | 6.78e-07 | 1429 | 79 | 15 | 35140242 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 1.72e-06 | 38 | 79 | 4 | 38086370 | |
| Pubmed | MTG8 interacts with LHX6 to specify cortical interneuron subtype identity. | 1.91e-06 | 39 | 79 | 4 | 36064547 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 35613264 | ||
| Pubmed | 4.15e-06 | 407 | 79 | 8 | 12693553 | ||
| Pubmed | PTPN4 NUP155 CAMSAP3 SEC16A KIAA1549 TANC1 CUL7 PUM1 NCKAP5L PLEKHA7 CDC42BPB PRRC2A | 4.25e-06 | 1049 | 79 | 12 | 27880917 | |
| Pubmed | 5.03e-06 | 15 | 79 | 3 | 34155146 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19766631 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32234710 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28963436 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7708064 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7626501 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8183930 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7609634 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15907456 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19160499 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8804707 | ||
| Pubmed | BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT. | 5.09e-06 | 2 | 79 | 2 | 25111513 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 2156268 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28922831 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX9 HIVEP1 SATB1 GLI1 KIAA1549 FOXI2 MAFB RERE NR2F1 NR2F2 TP73 | 6.48e-06 | 908 | 79 | 11 | 19274049 |
| Pubmed | 7.95e-06 | 591 | 79 | 9 | 15231748 | ||
| Pubmed | 8.09e-06 | 446 | 79 | 8 | 24255178 | ||
| Pubmed | 8.89e-06 | 57 | 79 | 4 | 35377797 | ||
| Pubmed | 9.97e-06 | 608 | 79 | 9 | 16713569 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TUBGCP6 HIVEP1 CAMSAP3 SEC16A BUD13 RERE PRRC2A BAG6 CNOT3 PHC2 | 1.02e-05 | 774 | 79 | 10 | 15302935 |
| Pubmed | Rab23 regulates differentiation of ATDC5 chondroprogenitor cells. | 1.53e-05 | 3 | 79 | 2 | 18218620 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 31474762 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 20626023 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 9632703 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25922524 | ||
| Pubmed | Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. | 1.53e-05 | 3 | 79 | 2 | 18565851 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 15677473 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 18701084 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.56e-05 | 351 | 79 | 7 | 38297188 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PTPN4 MBTPS1 LATS2 SETD5 KIAA1217 CAMSAP3 KNDC1 TANC1 GREB1 RERE UBN2 CDC42BPB TET3 | 2.92e-05 | 1489 | 79 | 13 | 28611215 |
| Pubmed | Orphan nuclear receptor COUP-TFII enhances myofibroblast glycolysis leading to kidney fibrosis. | 3.05e-05 | 4 | 79 | 2 | 34031962 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 18199540 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 25632159 | ||
| Pubmed | Anchorage of microtubule minus ends to adherens junctions regulates epithelial cell-cell contacts. | 3.05e-05 | 4 | 79 | 2 | 19041755 | |
| Pubmed | CNPY4 inhibits the Hedgehog pathway by modulating membrane sterol lipids. | 3.05e-05 | 4 | 79 | 2 | 35504891 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 33134768 | ||
| Pubmed | The COUP-TF nuclear receptors regulate cell migration in the mammalian basal forebrain. | 3.05e-05 | 4 | 79 | 2 | 15548577 | |
| Pubmed | TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides. | 3.05e-05 | 4 | 79 | 2 | 37932931 | |
| Pubmed | Tenascin-C expressing touch dome keratinocytes exhibit characteristics of all epidermal lineages. | 3.05e-05 | 4 | 79 | 2 | 38241368 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 10744719 | ||
| Pubmed | 4.11e-05 | 560 | 79 | 8 | 35241646 | ||
| Pubmed | TUBGCP6 ARHGEF40 SETD5 SEC16A KIAA1549 BUD13 TANC1 RERE CUL7 NCKAP5L TP73 | 4.34e-05 | 1116 | 79 | 11 | 31753913 | |
| Pubmed | 4.56e-05 | 282 | 79 | 6 | 23667531 | ||
| Pubmed | 4.84e-05 | 31 | 79 | 3 | 36362374 | ||
| Pubmed | A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. | 5.07e-05 | 5 | 79 | 2 | 9177236 | |
| Pubmed | Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). | 5.07e-05 | 5 | 79 | 2 | 18640976 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 5.07e-05 | 5 | 79 | 2 | 24360964 | |
| Pubmed | Inactivation of Patched1 in the mouse limb has novel inhibitory effects on the chondrogenic program. | 5.07e-05 | 5 | 79 | 2 | 20576618 | |
| Pubmed | The Adult Adrenal Cortex Undergoes Rapid Tissue Renewal in a Sex-Specific Manner. | 5.07e-05 | 5 | 79 | 2 | 31104943 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 15778499 | ||
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 5.67e-05 | 91 | 79 | 4 | 29513653 | |
| Pubmed | 5.67e-05 | 91 | 79 | 4 | 21194568 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.81e-05 | 180 | 79 | 5 | 35198878 | |
| Pubmed | Mammalian Sec16/p250 plays a role in membrane traffic from the endoplasmic reticulum. | 7.60e-05 | 6 | 79 | 2 | 17428803 | |
| Pubmed | Deciphering the origins and fates of steroidogenic lineages in the mouse testis. | 7.60e-05 | 6 | 79 | 2 | 35705036 | |
| Pubmed | Ciliopathy Protein Tmem107 Plays Multiple Roles in Craniofacial Development. | 7.60e-05 | 6 | 79 | 2 | 28954202 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 24466353 | ||
| Pubmed | Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice. | 7.60e-05 | 6 | 79 | 2 | 29100091 | |
| Pubmed | Conditional disruption of Nr5a1 directed by Sox9-Cre impairs adrenal development. | 7.60e-05 | 6 | 79 | 2 | 38811798 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 7947324 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 23990464 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 36931279 | ||
| Pubmed | Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas. | 7.60e-05 | 6 | 79 | 2 | 36443313 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 2813433 | ||
| Pubmed | Spatial control of astrogenesis progression by cortical arealization genes. | 7.60e-05 | 6 | 79 | 2 | 35818636 | |
| Pubmed | YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme. | 7.63e-05 | 36 | 79 | 3 | 28943241 | |
| Pubmed | Isolation and Characterization of Fetal Leydig Progenitor Cells of Male Mice. | 8.29e-05 | 37 | 79 | 3 | 26697723 | |
| Pubmed | 8.85e-05 | 102 | 79 | 4 | 11214970 | ||
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 9.72e-05 | 39 | 79 | 3 | 34921112 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.05e-04 | 475 | 79 | 7 | 31040226 | |
| Pubmed | CoupTFI interacts with retinoic acid signaling during cortical development. | 1.06e-04 | 7 | 79 | 2 | 23472160 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 20797425 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 9196000 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 35840551 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 20034104 | ||
| Pubmed | Transit-amplifying cells orchestrate stem cell activity and tissue regeneration. | 1.06e-04 | 7 | 79 | 2 | 24813615 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 30758073 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 24131628 | ||
| Pubmed | 1.12e-04 | 332 | 79 | 6 | 37433992 | ||
| Pubmed | 1.33e-04 | 493 | 79 | 7 | 15368895 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LENG8 MAST4 KIAA1217 SH3GL2 CAMSAP3 TANC1 SPATA2 NCKAP5L PLEKHA7 | 1.37e-04 | 853 | 79 | 9 | 28718761 |
| Pubmed | LENG8 BCL9L SETD5 CAMSAP3 BUD13 TANC1 UBN2 PLEKHA7 CDC42BPB PRRC2A CNOT3 PHC2 | 1.37e-04 | 1497 | 79 | 12 | 31527615 | |
| Pubmed | Ihh and Runx2/Runx3 signaling interact to coordinate early chondrogenesis: a mouse model. | 1.41e-04 | 8 | 79 | 2 | 23383321 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 26939755 | ||
| Pubmed | Perivascular hair follicle stem cells associate with a venule annulus. | 1.41e-04 | 8 | 79 | 2 | 23558405 | |
| Pubmed | Pervasive translational regulation of the cell signalling circuitry underlies mammalian development. | 1.41e-04 | 8 | 79 | 2 | 28195124 | |
| Pubmed | Testosterone levels influence mouse fetal Leydig cell progenitors through notch signaling. | 1.41e-04 | 8 | 79 | 2 | 23467742 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 19268447 | ||
| Pubmed | PFGE mapping and RFLP analysis of the S/D region of the mouse H-2 complex. | 1.41e-04 | 8 | 79 | 2 | 1351875 | |
| Interaction | FXR2 interactions | RNF214 HIVEP1 CD6 GLI1 KIAA1217 MAFB PUM1 PRRC2A CNOT3 INPP5J PHC2 | 6.92e-07 | 430 | 77 | 11 | int:FXR2 |
| Interaction | YWHAG interactions | PTPN4 HIVEP1 LATS2 MAST4 PIK3C2B SPEG CAMSAP3 SEC16A ARHGAP17 MAFB FAM124A TANC1 ATG9A CUL7 PUM1 NCKAP5L PLEKHA7 OTOG | 7.87e-07 | 1248 | 77 | 18 | int:YWHAG |
| Interaction | MEX3B interactions | 2.09e-06 | 222 | 77 | 8 | int:MEX3B | |
| Interaction | YWHAH interactions | PTPN4 HIVEP1 LATS2 MAST4 PIK3C2B SPEG KIAA1217 CAMSAP3 SEC16A ARHGAP17 TANC1 ATG9A PUM1 NCKAP5L PLEKHA7 OTOG | 3.34e-06 | 1102 | 77 | 16 | int:YWHAH |
| Interaction | CEP85 interactions | 3.78e-06 | 169 | 77 | 7 | int:CEP85 | |
| Interaction | FOXP2 interactions | 7.12e-06 | 70 | 77 | 5 | int:FOXP2 | |
| Interaction | YWHAZ interactions | PTPN4 HIVEP1 LATS2 MAST4 PIK3C2B SPEG CAMSAP3 FAM124A TANC1 ATG9A CUL7 SPATA2 PUM1 NCKAP5L PLEKHA7 PRRC2A OTOG | 7.69e-06 | 1319 | 77 | 17 | int:YWHAZ |
| Interaction | TOP3B interactions | ANKS6 ARHGEF40 LATS2 PELP1 PIK3C2B SETD5 GLI1 SPEG SEC16A ARHGAP17 TANC1 ATG9A PUM1 CDC42BPB PRRC2A NR2F2 C8orf58 PHC2 | 7.98e-06 | 1470 | 77 | 18 | int:TOP3B |
| Interaction | TNRC6B interactions | 1.21e-05 | 282 | 77 | 8 | int:TNRC6B | |
| Interaction | MAPRE3 interactions | 2.81e-05 | 230 | 77 | 7 | int:MAPRE3 | |
| Interaction | EEF1D interactions | 3.99e-05 | 333 | 77 | 8 | int:EEF1D | |
| Interaction | DYRK1A interactions | LATS2 NUP155 GLI1 KIAA1217 SH3GL2 SEC16A KNDC1 TANC1 CNOT3 SLX4 | 4.63e-05 | 552 | 77 | 10 | int:DYRK1A |
| Interaction | SYNE3 interactions | LATS2 NUP155 KIAA1217 CAMSAP3 SEC16A SPATA2 PUM1 NCKAP5L PLEKHA7 | 4.83e-05 | 444 | 77 | 9 | int:SYNE3 |
| Interaction | FXR1 interactions | RNF214 HIVEP1 CD6 GLI1 SH3GL2 SEC16A MAFB CUL7 PUM1 PRRC2A PHC2 | 5.18e-05 | 679 | 77 | 11 | int:FXR1 |
| Interaction | LCK interactions | PIK3C2B KIAA1217 KIAA1549 ARHGAP17 TANC1 NCKAP5L PLEKHA7 CDC42BPB BAG6 | 6.67e-05 | 463 | 77 | 9 | int:LCK |
| Interaction | ZFP36 interactions | 6.75e-05 | 181 | 77 | 6 | int:ZFP36 | |
| Interaction | FAM120C interactions | 9.09e-05 | 191 | 77 | 6 | int:FAM120C | |
| Interaction | MEX3A interactions | 1.08e-04 | 384 | 77 | 8 | int:MEX3A | |
| Interaction | YWHAB interactions | PTPN4 HIVEP1 MAST4 PIK3C2B SPEG CAMSAP3 TANC1 ATG9A CUL7 PUM1 NCKAP5L PLEKHA7 OTOG | 1.12e-04 | 1014 | 77 | 13 | int:YWHAB |
| Interaction | BAG2 interactions | TUBGCP6 RNF214 LATS2 ARHGAP17 GREB1 CUL7 PUM1 UBN2 CNOT3 NR2F2 | 1.24e-04 | 622 | 77 | 10 | int:BAG2 |
| Interaction | TEAD2 interactions | 1.41e-04 | 130 | 77 | 5 | int:TEAD2 | |
| Interaction | MAPRE1 interactions | MAST4 NUP155 KIAA1217 CAMSAP3 SEC16A ARHGAP17 TANC1 NCKAP5L PRRC2A | 1.47e-04 | 514 | 77 | 9 | int:MAPRE1 |
| Interaction | TNRC6C interactions | 1.86e-04 | 138 | 77 | 5 | int:TNRC6C | |
| Interaction | REG1B interactions | 2.14e-04 | 6 | 77 | 2 | int:REG1B | |
| Interaction | SMG7 interactions | 2.17e-04 | 319 | 77 | 7 | int:SMG7 | |
| Interaction | RNF43 interactions | 2.23e-04 | 427 | 77 | 8 | int:RNF43 | |
| Interaction | CDKN2AIPNL interactions | 2.23e-04 | 31 | 77 | 3 | int:CDKN2AIPNL | |
| Interaction | YWHAE interactions | PTPN4 HIVEP1 MAST4 PIK3C2B CAMSAP3 FAM124A TANC1 CUL7 SPATA2 PUM1 NCKAP5L PLEKHA7 PRRC2A OTOG | 2.58e-04 | 1256 | 77 | 14 | int:YWHAE |
| Cytoband | 11q23.3 | 3.40e-04 | 78 | 79 | 3 | 11q23.3 | |
| GeneFamily | N-BAR domain containing | 3.76e-04 | 12 | 44 | 2 | 1289 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | LENG8 RNF214 SETD5 ARHGAP17 CUL7 SEC31B NCKAP5L PRRC2A CNOT3 | 8.26e-07 | 338 | 79 | 9 | M17094 |
| Coexpression | HOELZEL_NF1_TARGETS_DN | 2.93e-05 | 118 | 79 | 5 | M2143 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 3.20e-05 | 200 | 79 | 6 | M7911 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | CACNA1A SOX9 BCL9L ANKS6 ARHGEF40 TOX PIK3C2B SETD5 GLI1 SEC16A KIAA1549 ARHGAP17 MAFB RUNX1T1 GFRA4 NCKAP5L PRRC2A NR2F1 | 1.85e-07 | 1208 | 76 | 18 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-07 | 185 | 79 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-06 | 193 | 79 | 6 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 194 | 79 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-06 | 195 | 79 | 6 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-06 | 195 | 79 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-06 | 198 | 79 | 6 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-06 | 198 | 79 | 6 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 169 | 79 | 5 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 174 | 79 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 179 | 79 | 5 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-05 | 179 | 79 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 1.72e-05 | 180 | 79 | 5 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 181 | 79 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 183 | 79 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 186 | 79 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.07e-05 | 187 | 79 | 5 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 187 | 79 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 189 | 79 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 189 | 79 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 189 | 79 | 5 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 189 | 79 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-05 | 190 | 79 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-05 | 190 | 79 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 190 | 79 | 5 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 190 | 79 | 5 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 190 | 79 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 190 | 79 | 5 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 191 | 79 | 5 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 191 | 79 | 5 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 191 | 79 | 5 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-05 | 192 | 79 | 5 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 192 | 79 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 193 | 79 | 5 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | 4a8c97ff2dffc5c06351d1cb107e21e58250aa55 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 79 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 194 | 79 | 5 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-05 | 194 | 79 | 5 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 194 | 79 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-05 | 194 | 79 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-05 | 194 | 79 | 5 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-05 | 194 | 79 | 5 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 194 | 79 | 5 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 2.46e-05 | 194 | 79 | 5 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-05 | 195 | 79 | 5 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.59e-05 | 196 | 79 | 5 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 198 | 79 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.85e-05 | 200 | 79 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.85e-05 | 200 | 79 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-05 | 200 | 79 | 5 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 100 | 79 | 4 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.80e-05 | 118 | 79 | 4 | c351e465ece4f3767b2c19e695eca3c263c68777 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 145 | 79 | 4 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-04 | 147 | 79 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 155 | 79 | 4 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.67e-04 | 155 | 79 | 4 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 157 | 79 | 4 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 157 | 79 | 4 | 0a552abfd139afc8516c38ca568f9922511dddce | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 157 | 79 | 4 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.84e-04 | 159 | 79 | 4 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 160 | 79 | 4 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.88e-04 | 160 | 79 | 4 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.97e-04 | 162 | 79 | 4 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-04 | 162 | 79 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-04 | 162 | 79 | 4 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 166 | 79 | 4 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| Disease | cortical surface area measurement | CACNA1A PRR23A MAST4 RP1L1 PERM1 RERE RUNX1T1 PLEKHA7 PRRC2A NR2F1 NR2F2 PHC2 | 1.59e-04 | 1345 | 76 | 12 | EFO_0010736 |
| Disease | level of Triacylglycerol (53:4) in blood serum | 1.81e-04 | 8 | 76 | 2 | OBA_2045166 | |
| Disease | Abnormality of the face | 2.33e-04 | 9 | 76 | 2 | C4025871 | |
| Disease | smoking behavior | 2.52e-04 | 341 | 76 | 6 | EFO_0004318 | |
| Disease | psychological resilience measurement | 4.25e-04 | 12 | 76 | 2 | EFO_0009945 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 5.01e-04 | 13 | 76 | 2 | OBA_2045159 | |
| Disease | ureidopropionic acid measurement | 7.67e-04 | 16 | 76 | 2 | EFO_0010542 | |
| Disease | age at menarche | 8.52e-04 | 594 | 76 | 7 | EFO_0004703 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 8.68e-04 | 17 | 76 | 2 | EFO_0008270 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 9.75e-04 | 18 | 76 | 2 | OBA_2045155 | |
| Disease | Autism Spectrum Disorders | 1.39e-03 | 85 | 76 | 3 | C1510586 | |
| Disease | eosinophil count | FNDC1 HIVEP1 PELP1 PIK3C2B SEC16A BUD13 MAFB RERE SPATA2 TET3 PHC2 | 1.45e-03 | 1488 | 76 | 11 | EFO_0004842 |
| Disease | Cerebral Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C1704230 | |
| Disease | Ataxia | 1.89e-03 | 25 | 76 | 2 | C0004134 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.89e-03 | 25 | 76 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.89e-03 | 25 | 76 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 2.04e-03 | 26 | 76 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.04e-03 | 26 | 76 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.04e-03 | 26 | 76 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 2.20e-03 | 27 | 76 | 2 | C0334579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRRTPNNPGNPSNPG | 1121 | O00555 | |
| SPPRRPQHNSSGASP | 201 | Q9BRD0 | |
| SGPSPRLDSNPTGAH | 151 | Q5SNV9 | |
| GPRNSPSLQPPHPGS | 1476 | Q8TER5 | |
| QARPSHPGGPPVSGT | 511 | P46379 | |
| QQPPASTPGHGPSDS | 276 | Q3KPI0 | |
| SRSRAAQSPGPPHNG | 26 | O94989 | |
| AQSPGPPHNGSSPQE | 31 | O94989 | |
| STRAPLPSPLHTPGN | 226 | Q8NAV2 | |
| GPGPSQSPRSPKHTR | 771 | Q9P1Y5 | |
| SSQALGPPSGPHNPP | 451 | O75175 | |
| SGAPHTPQTPGQPGA | 46 | P10589 | |
| APHTPQTPGQGGPAS | 36 | P24468 | |
| QSLPSRSPPGTPNHR | 386 | P29074 | |
| RSHRAPQSGPPLPSS | 1441 | Q9HCM3 | |
| SGHPSPAPPDQLNTS | 16 | P30203 | |
| AASPAQQLPTSHPGP | 176 | Q9Y5Q3 | |
| PPDHGSSGTPSKNLP | 1131 | Q9HCH0 | |
| PPSLSHSGNRQRPPS | 876 | Q14703 | |
| ASQGPPSAISRHSPG | 1181 | Q4ZG55 | |
| TNSFNSHQPRPGPPG | 406 | Q9NRM7 | |
| SHSPTALNGAPSPPN | 81 | Q06455 | |
| NPPHGAHTLNSGPQP | 171 | Q96PV6 | |
| SSAPPGQAQATAHPP | 11 | Q6ZQN5 | |
| THAPQTLNPSPGFAP | 281 | Q6ZQN5 | |
| GSSQQSPLNSPHPGP | 316 | Q86V42 | |
| HTESLNPGSSGPNPP | 1656 | Q14999 | |
| NPGSSGPNPPLTFHT | 1661 | Q14999 | |
| PSSAQRSPGPRPSAH | 541 | Q6NV75 | |
| QTQPPSGSRPPSQHR | 146 | Q96MY7 | |
| DQRGSSGHTPPPSGP | 1066 | P08151 | |
| PRPQQSPPGHTSQSA | 1291 | Q96RT7 | |
| NSSNPSGPPSPNSPH | 1681 | Q9Y5S2 | |
| SGPPSPNSPHRSQLP | 1686 | Q9Y5S2 | |
| PSARPGPPTTANHLG | 696 | Q8IZL8 | |
| NPSFLGTPSHGIQPP | 616 | O75694 | |
| QGPGHSQTPPPSLSS | 751 | Q14671 | |
| GPPNHSTSQGPQPGS | 101 | O00750 | |
| VGQPPPHSSAATPNL | 431 | O15350 | |
| HRPPAAQASPPGLSG | 151 | Q9GZZ7 | |
| SPQRATSPHQGASPP | 376 | H7BZ55 | |
| HAASPARPSRPGGPQ | 1131 | Q4ZHG4 | |
| SPLQPGQAPTGRAHS | 656 | Q7Z3C6 | |
| SNPPGTVHSAPNRGL | 896 | Q86UU0 | |
| QKPSHRSSPVGPAPG | 681 | Q68DC2 | |
| APNSPAGSGHIRPST | 1336 | O15021 | |
| SPLSNNHPPTPKRRG | 76 | Q9Y5P2 | |
| GSPGQPETSHPSQGP | 391 | Q76NI1 | |
| GGSSLSLHPPQQPPL | 111 | Q8NEL9 | |
| SPKSPGHSTGSQRPP | 156 | Q5SV97 | |
| GHGSLPVRTTPPQPS | 1636 | Q6ZRI0 | |
| HSTPLPPQGSGQPRG | 406 | Q6ZVC0 | |
| PSNTSAPHSQGGIPP | 241 | Q16563 | |
| LAPNPSSEGHSPGPF | 201 | A6NEV1 | |
| AVHPTQPSSNPAGRG | 1576 | Q9UPZ6 | |
| SPPTQHTGQPPGQPS | 676 | Q68EM7 | |
| HTGQPPGQPSAPSQL | 681 | Q68EM7 | |
| STRHPSGGSSPPPRN | 476 | Q6IQ23 | |
| QLHPNSGGFRPGTPS | 1856 | P48634 | |
| ASNPLSPQTGPPAHS | 1836 | Q5T5P2 | |
| TTALRPGNPPSHGSS | 1276 | Q9C0A6 | |
| SPGPPQPGTLRKSHA | 1026 | Q9C0D5 | |
| SPHPPLQPLTGSAGQ | 821 | Q9P2R6 | |
| GSAGQPSAPSHAQPP | 831 | Q9P2R6 | |
| GLTQSQNLPPPPASH | 1006 | Q9P2R6 | |
| RLGSQPSHQVPTPSP | 816 | Q9NQW1 | |
| EHSGQSQGPPTPPTT | 226 | P48436 | |
| HSRGKSPPRPGNSQP | 176 | Q6PIF2 | |
| PATASNHPLNPGATP | 756 | Q9NZP6 | |
| QPPSPAQLSHGSQPS | 281 | Q01826 | |
| HSPPGPSFLNQTPAG | 1376 | Q8IY92 | |
| PPVPQHPSGNSRSAL | 106 | Q8N7H1 | |
| GHLQPPAQTSGPTGS | 251 | Q15735 | |
| PSQPSSPLPGSHGRN | 496 | Q8ND24 | |
| PGGSQPLPTPAQSRN | 256 | Q8IXK0 | |
| HGSPDVLPPASPSNG | 306 | Q9UM82 | |
| TPSPGNGSQGSHPLV | 986 | Q6ZU65 | |
| PHLPRSNPGSSQPSG | 996 | P61129 | |
| QSVASHPRQSGPGAP | 1021 | O15027 | |
| GHAQGPSQGPAAPPS | 2256 | Q15772 | |
| DTPHQRPGSQTGPSS | 2286 | Q8IWN7 | |
| TQPNGGLSHTGTPKP | 271 | Q99962 | |
| QAHPPAPLPASQGSA | 641 | O43151 | |
| GGSNVPHNSPSPPGS | 196 | O94900 | |
| SGPNAPVPQSGHPRT | 881 | P15822 | |
| AEPPPRGSPGNGSSH | 296 | Q9BRK3 |